KLK3 and neoplasm: Regardless, we were pleased to see our GZMB pro-drug to have these effects on several lines in the presence of PSA as well as human prostate stromal cells which suggests that GZMB could have the capacity to disrupt the tissue architecture in a tumor which would yield a more comprehensive response.